Murine model of primary intraocular lymphoma.

[1]  Chi-Chao Chan,et al.  Molecular pathology of primary intraocular lymphoma. , 2004, Transactions of the American Ophthalmological Society.

[2]  C. Colin,et al.  Biological diagnosis of primary intraocular lymphoma , 2004, British journal of haematology.

[3]  M. Fromer,et al.  The leader peptide of MMTV Env precursor localizes to the nucleoli in MMTV-derived T cell lymphomas and interacts with nucleolar protein B23. , 2003, Virology.

[4]  R. Nussenblatt,et al.  Vitreous cytokine levels. , 2003, Ophthalmology.

[5]  C. Chan.  Primary intraocular lymphoma: clinical features, diagnosis, and treatment. , 2003, Clinical lymphoma.

[6]  L. Deangelis,et al.  Primary ocular lymphoma: clinical features, diagnosis, and treatment. , 2003, Clinical lymphoma.

[7]  P. Mckelvie,et al.  Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes , 2003, Eye.

[8]  S. Lightman,et al.  Pseudo‐hypopyon as the presenting feature in B‐cell and T‐cell intraocular lymphoma , 2003, Clinical & experimental ophthalmology.

[9]  Takayuki Takahashi,et al.  The Serum Cytokine Profiles of Lymphoma-associated Hemophagocytic Syndrome: A Comparative Analysis of B-Cell and T-Cell/Natural Killer Cell Lymphomas , 2003, International journal of hematology.

[10]  Justine R. Smith,et al.  Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma. , 2003, Blood.

[11]  R. Buggage,et al.  Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma. , 2003, Ophthalmology (Rochester, Minn.).

[12]  R. Nussenblatt,et al.  Intraocular lymphoma , 2002, Current opinion in ophthalmology.

[13]  N. Rao,et al.  Neoplastic masquerade syndromes. , 2002, Survey of ophthalmology.

[14]  L. Deangelis,et al.  Primary central nervous system T-cell lymphoma , 2001, Neurology.

[15]  O. Wiestler,et al.  Entry routes of malignant lymphoma into the brain and eyes in a mouse model. , 2001, Cancer research.

[16]  K. Lueders,et al.  Differential expression of intracisternal A-particle transcripts in immunogenic versus tumorigenic S49 murine lymphoma cells. , 2000, Virology.

[17]  K. Zachmann,et al.  T-cell clones from early-stage cutaneous T-cell lymphoma show no polarized Th-1 or Th-2 cytokine profile , 2000, Archives of Dermatological Research.

[18]  R. Gascoyne,et al.  Use of the polymerase chain reaction to detect B- and T-cell gene rearrangements in vitreous specimens from patients with intraocular lymphoma. , 1999, Archives of ophthalmology.

[19]  O. Wiestler,et al.  An experimental model for infiltration of malignant lymphoma to the eye and brain , 1997, Virchows Archiv.

[20]  J. Shadduck,et al.  Immunogenetic basis for immunologic privilege in the anterior chamber of the eye , 2004, Immunogenetics.

[21]  C. Chan,et al.  Newer methodologies in immunohistochemistry and diagnosis. , 1999, Developments in ophthalmology.

[22]  H. Grossniklaus.  Tumor vascularity and hematogenous metastasis in experimental murine intraocular melanoma. , 1998, Transactions of the American Ophthalmological Society.

[23]  H. Grossniklaus,et al.  Murine model of anterior and posterior ocular melanoma. , 1995, Current eye research.